Skip to main content
You can make a positive impact

BE A GAME CHANGER

Our mission is to improve public health worldwide. Join us as we work to make the world a healthier place.

#PioneeringDiagnostics

News

Closing of the acquisition of Specific Diagnostics

bioMérieux announces that it has finalized the acquisition of Specific Diagnostics, a privately held U.S. based company that has developed a rapid antimicrobial susceptibility test (AST) system that delivers phenotypic AST directly from positive blood cultures.

< SWIPE FOR MORE STORIES >

bioMérieux announces the CE marking of VIDAS® tests for Chikungunya virus diagnosis

VIDAS® Anti-CHIKUNGUNYA IgM and Anti-CHIKUNGUNYA IgG are new automated tests intended as an aid in the diagnosis of Chikungunya virus infection. Used on the VIDAS® family platforms, these tests provide reliable results with better traceability than existing manual methods. 

The Four Key Benefits of Rapid Micro Methods

Rapid microbiological methods (RMMs) encompass any technology that allows a user to get microbiology results faster compared to traditional methods. RMMs were first commercialized in the 1990’s, but the pharmaceutical and biopharmaceutical industries have been slow to embrace these faster technologies. 

Eco-design: more sober, lighter and more responsible packaging

We have developed more environmentally friendly brown packaging for our VIDAS® pilot range. They are now extended to other ranges.

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

This dedication to public health is the thread that connects everything we do. It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and sharing.